A 42-year-old Chinese man, known case of renal cell carcinoma with lung metastasis, was referred to Universiti Kebangsaan Malaysia Medical Centre for left eye blurring of vision for one month duration, which was worse upon waking up in the morning and cleared up after 1-2 hours. On examination, visual acuities were 6/6 in both eyes. No relative afferent pupillary defect. Left fundus showed inferonasal retinal detachment without macular involvement. No retina break, no retinitis and no choroidal lesion seen. Right eye examination was normal. Optical coherence tomography (OCT) of left eye showed subretinal fluid temporal and inferior to optic disc. Fundus fluorescein angiography (FFA) left eye showed hypofluoresence in early phase but hyperfluorescence with pin point leakage in late phase over inferonasal quadrant. Indocyanine green (ICG) showed early hypofluoresence with late pin point hyperfluoresence in the same quadrant. A clinical diagnosis of exudative retinal detachment due to choroidal metastasis secondary to renal cell carcinoma was made. The patient was planned for cyber-knife radiotherapy of his left eye but unfortunately we lost the follow up. High index of suspicion and relevant investigation are needed for patients with visual complaints and history of renal cell carcinoma to diagnose choroidal metastasis.
Introduction
The prevalence of uveal metastases from all forms of carcinoma is between 2.3% to 9.2% (1) . The leading sites of primary cancer metastasis to uveal are breast (47%) and lung (21%), follow by gastrointestinal tract (4%), skin (2%), prostate (2%) and kidney (2%) (2) . Renal cell carcinoma accounts for approximately 3% of adult malignancy (3) and frequently metastasizes via venous and lymphatic systems to lung, regional lymph nodes, liver, bone, and subcutaneous tissues. However, ocular metastasis from renal cell carcinoma have been reported to involve iris, ciliary body, choroids, eyelid, conjunctiva and lacrimal gland (4) (5) (6) (7) . In this paper, we describe a case of choroidal metastasis from renal cell carcinoma that presented with exudative retinal detachment and the characteristic features in angiography.
Case Report
A 42-year-old man presented with one month history of blurring of vision over the left eye which was worse after waking up in the morning and resolved after one to two hours. He was diagnosed to have stage 4 renal cell carcinoma with lung metastasis just one month prior to the onset of his ocular symptom. He was commenced on oral Pazopanib as the primary was deemed inoperable. A brain and orbital magnetic resonance imaging (MRI) had done at a private center prior and it reported possible metastasis to the brain and the left orbit. On examination, visual acuities were 6/6 in both eyes. The pupillary reactions were normal. Left eye conjunctiva vessels appeared dilated infero-nasally. Left fundus showed inferonasal retinal detachment without macular involvement. Shifting fluid was demonstrated. There was no retinal break, retinitis, choroiditis or mass seen. Right eye examination was unremarkable.
Optical coherence tomography (OCT) analysis of the retinal layer revealed presence of subretinal fluid nasal and inferior to optic disc ( Fig. 1a and 1b) . Otherwise, there was no intraretinaloedema or thickening of retinal pigmented epithelium (RPE). Fundus fluorescein angiography (FFA) of left eye showed a lesion which was hypofluorescence in early phase but had diffuse pinpoint leakages in late phase at the inferonasal quadrant, underneath the retinal detachment ( Fig. 2a and 2b ). Indocyanine green (ICG) also showed early hypofluorescence with late pinpoint hyperfluorescence in the same quadrant ( Fig. 2c and  2d ). These findings were commonly seen in choroidal metastatic tumour.
A clinical diagnosis of exudative retinal detachment due to choroidal metastasis secondary to renal cell carcinoma was made. The patient was planned for cyber-knife radiotherapy of his left eye. However, he defaulted subsequent follow ups.
Discussion
Uvea is the vascular middle layer of the eye and is divided into iris, ciliary body and choroid. Choroid is a highly vascularized structure which supply nutrient and provides gas exchange for the outer part of the retina. In a survey of 950 uveal metastatic foci in 520 eyes, choroid was the most common site of metastasis (88%) followed by the iris (9%), and the ciliary body (2%) (2). Choroid is highly vascularized and thus easily accessible by neoplastic cells which travel as emboli. For a tumour to metastasize from a distant site to the eye, the tumour emboli needs to pass through the internal carotid artery, ophthalmic artery, ciliary arteries and eventually the uveal tract to reach the choroidal layer (8) . Choroidal metastasis is usually located at the posterior pole as tumour emboli is likely to reach the eye via short posterior ciliary arteries than through the longer and less numerous anterior vessels (8) . Choroidal metastasis could be asymptomatic (2) if the lesion is small and located at the periphery. It usually becomes symptomatic when the lesion involves the macula and optic nerve or produce exudative retinal detachment involving the macular (9) as in our case. The hallmark for exudative retinal detachment is shifting fluid, which means that when the patient is lying down, the subretinal fluid accumulates in the macular area which contributes to the blurring of vision upon waking up. In upright position, the subretinal fluid will shift inferior to macular resulting in clearing up of the vision.
Other ocular pathological conditions that may mimic choroidal metastasis are melanoma, lymphoma, choroidal haemangioma and choroidal osteoma. Investigations that aid in evaluation of these tumours include fluorescein angiography and indocyanine green angiography. Angiographic features for choroidal metastases are variable. The most commonly reported feature is hypofluorescence in the arterial and early venous phases in fluorescein angiography and becomes progressively hyperfluorescent with multiple pinpoint spotin the venous and late phases (9, 10) . Similar features were seen in our case. Other less common findings include normal fluorescence throughout the angiogram (9), hyperfluorescence in early phase which increases in late phase or early fluorescence in arteriovenous phase which further diminished in late phases (11) . Pooling of dye occurs within the area of exudative retinal detachment in late phases (9, 11) . In our case, the fluorescein angiography revealed hypofluorescence in the early phase and pinpoint hyperfluorescence in the late phase within the area of exudative detachment (inferonasalquadrant). Neurosensory detachment together with localized area of metastatic tumour cells within the choroid surrounding the associated vasculature causing early hypofluorescence by blocking the light transmission. The pinpoint leakage seen in late phase was due to alteration in the overlying retinal pigment epithelium (12) . It was postulated that abnormal vessels of tumours are more permeable and congested leading to change of oncotic and hydrostatic pressure resulting in neurosensory detachment (9) .
In a study of indocyanine green (ICG) videoangiographic findings in 5 cases of choroidal metastatic tumour, ICG is reported as a better modality in demonstrating the exact size of the tumour associated with serous retinal detachment as the infrared light can penetrate the detached retina and allow visualization of the choroidal lesion. Blocked fluorescent area seen in the early phase corresponded to the tumour. Late phase angiogram showed hyperfluorescence due to dye leakage through abnormal retinal pigment epithelium (12) . Similar angiographic finding was noted in our patient. ICG in conjunction with fluorescein angiography are important in diagnosing and monitoring treatment response in cases of choroidal metastasis (12) .
Treatment for choroidal metastasis include systemic chemotherapy and/or hormonal therapy, radiotherapy (external beam, plaque brachytherapy, Gamma knife, cyber-knife, proton beam), transpupillary thermotherapy, laser photocoagulation/photodynamic therapy, intravitreal injection, cryotherapy, resection or enucleation (1, 13) . Evidence-based analysis favours radiotherapy for the sight-threatening uveal metastasis (1). Cyber-knife radiotherapy is offered to this patient as the system incorporated a newer noninvasive eye fixation monitoring system which obviates the need for muscle sutures, implanted radio-opaque markers and retrobulbar anesthesia. Cyber-knife delivers fractionated radiotherapy that causes less radiation damage to surrounding structures such as lens and ciliary body.
The prognosis for choroidal metastasis is generally poor. The mean survival after onset of metastatic disease is 8 to 9 months (14) .
Conclusion
Patient with renal cell carcinoma can present with exudative retinal detachment secondary to choroidal metastasis. This case highlights the angiographic features that can be seen inchoroidal metastasis.
